ArticleAnnals of medicine and surgery (2012)2026
A 16-year-old female with Kala Pathar poisoning, complicated by uncommon cardiac and hepatic manifestations: a rare case report of intensive care management.
Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction and importance: In the subcontinent, hair color containing paraphenylenediamine (PPD) is frequently used due to its affordability and easy accessibility. When administered topically or consumed, PPD has harmful effects both locally and systemically. Since there is no known cure, early detection and supportive interventions are the cornerstones of care. Case presentation: We now describe the effective treatment of a young female patient who experienced angioedema, cardiac manifestations, and hepatic dysfunction following PPD ingestion. Clinical signs such as angioedema and dark brown urine may indicate PPD toxicity in the absence of testing facilities. Clinical discussion: When taken orally, it is highly hazardous, and the results are primarily dependent on the dosage. Angioedema resulting in dysphagia and respiratory distress, hepatic necrosis, rhabdomyolysis, intravascular hemolysis, and abrupt renal failure are significant clinical symptoms. In PPD poisoning, myocarditis or deadly arrhythmias are also possible outcomes. Conclusion: Healthcare providers should maintain vigilance in regions where PPD exposure is prevalent, and public awareness and product regulation measures are necessary to mitigate the risks associated with PPD-containing products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.